For new or updated text, view the 2011 Focused Update. Text supporting unchanged
recommendations has not been updated. The ACC/AHA Task Force on Practice Guidelines …

In the advanced stages of heart failure, many key enzymes involved in myocardial energy
substrate metabolism display various degrees of down-regulation. The net effect of the …

(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies …

Background Results of previous studies support the hypothesis that implantable
haemodynamic monitoring systems might reduce rates of hospitalisation in patients with …

For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on
Dabigatran. Text supporting unchanged recommendations has not been updated. Atrial …

Objectives: The purpose of this study was to determine the prevalence and prognostic role of
left ventricular reverse remodeling (LVRR) in idiopathic dilated cardiomyopathy (IDCM) …

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the
Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction …

“A 57-year-old patient with a history of heart failure states that she began experiencing
worsening shortness of breath 4 days prior to admission, with lower extremity edema …

Carvedilol is one of the most effective beta blockers for preventing ventricular
tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic …

Despite the absence of a systematic development plan, β-blockers have reached the top tier
of medical therapies for chronic heart failure. The successful outcome was due to the many …